Loss of Thioredoxin-Binding Protein-2/Vitamin D3 Up-Regulated Protein 1 in Human T-Cell Leukemia Virus Type I-Dependent T-Cell Transformation: Implications for Adult T-Cell Leukemia Leukemogenesis

Cancer Research

Volumn 64, Issue 4, 2004, Pages 1287-1292

  Nishinaka, Yumiko ^a   Nishiyama, Akira ^b   Masutani, Hiroshi ^a,b   Oka, Shin Ichi ^a   Ahsan, Kaimul Md ^b   Nakayama, Yukie ^b   Ishii, Yasuyuki ^a   Nakamura, Hajime ^b   Maeda, Michiyuki ^c   Yodoi, Junji ^a,b  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; COLECALCIFEROL; THIOREDOXIN BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE G1 PHASE; CELL GROWTH; CONTROLLED STUDY; GENE OVEREXPRESSION; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKEMOGENESIS; LYMPHOCYTE TRANSFORMATION; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; T CELL LEUKEMIA; T LYMPHOCYTE; UPREGULATION; VIRUS CARRIER;

CARRIER PROTEINS; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERLEUKIN-2; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; T-LYMPHOCYTES; THIOREDOXIN;

EID: 10744219846     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-0908     Document Type: Article

References (40)

1. Yodoi, J., Takatsuki, K., and Masuda, T. Two cases of T-cell chronic lymphocytic leukemia in Japan. N. Engl. J. Med., 290: 572-573, 1974.
2. Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., and Gallo, R. C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA, 77: 7415-7419, 1980.
3. Hinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K. I., Shirakawa, S., and Miyoshi, I. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA, 78: 6476-6480, 1981.
4. Uchiyama, T., and Yodoi, J. (eds.). Adult T Cell Leukemia and Related Diseases, p. 139. Austin: R. G. Landes Co., 1995.
5. Yodoi, J., and Uchiyama, T. Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulation. Immunol. Today, 13: 405-411, 1992.
6. Gallo, R. C. Human retroviruses after 20 years: a perspective from the past and prospects for their future control. Immunol. Rev., 185: 236-265, 2002.
7. Okamoto, T., Ohno, Y., Tsugane, S., Watanabe, S., Shimoyama, M., Tajima, K., Miwa, M., and Shimotohno, K. Multi-step carcinogenesis model for adult T-cell leukemia. Jpn. J. Cancer Res., 80: 191-195, 1989.
8. Maeda, M., Shimizu, A., Ikuta, K., Okamoto, H., Kashihara, M., Uchiyama, T., Honjo, T., and Yodoi, J. Origin of human T-lymphotrophic virus I-positive T cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangement. J. Exp. Med., 162: 2169-2174, 1985.
9. Maeda, M., Arima, N., Daitoku, Y., Kashihara, M., Okamoto, H., Uchiyama, T., Shirono, K., Matsuoka, M., Hattori, T., Takatsuki, K., et al. Evidence for the interleukin-2 dependent expansion of leukemic cells in adult T cell leukemia. Blood, 70: 1407-1411, 1987.
10. Jeang, K. T. Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-κ B. Cytokine Growth Factor Rev., 12: 207-217, 2001.
11. Yoshida, M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu. Rev. Immunol., 19: 475-496, 2001.
12. Yodoi, J., and Tursz, T. ADF, a growth-promoting factor derived from adult T cell leukemia and homologous to thioredoxin: involvement in lymphocyte immortalization by HTLV-I and EBV. Adv. Cancer Res., 57: 381-411, 1991.
13. Teshigawara, K., Maeda, M., Nishino, K., Nikaido, T., Uchiyama, T., Tsudo, M., Wano, Y., and Yodoi, J. Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression. J. Mol. Cell. Immunol., 2: 17-26, 1985.
14. Tagaya, Y., Maeda, Y., Mitsui, A., Kondo, N., Matsui, H., Hamuro, J., Brown, N., Arai, K., Yokota, T., Wakasugi, H., et al. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J., 8: 757-764, 1989.
15. Holmgren, A. Thioredoxin. Annu. Rev. Biochem., 54: 237-271, 1985.
16. Nakamura, H., Nakamura, K., and Yodoi, J. Redox regulation of cellular activation. Annu. Rev. Immunol., 15: 351-369, 1997.
17. Haendeler, J., Hoffmann, J., Tischler, V., Berk, B. C., Zeiher, A. M., and Dimmeler, S. Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nat. Cell Biol., 4: 743-749, 2002.
18. Nishiyama, A., Matsui, M., Iwata, S., Hirota, K., Masutani, H., Nakamura, H., Takagi, Y., Sono, H., Gon, Y., and Yodoi, J. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J. Biol. Chem., 274: 21645-21650, 1999.
19. Chen, K. S., and DeLuca, H. F. Isolation and characterization of a novel cDNA from HL-60 cells treated with 1, 25-dihydroxyvitamin D-3. Biochim. Biophys. Acta, 1219: 26-32, 1994.
20. Maeda, M. Human T lymphotropic virus type-I (HTLV-I) immortalizes human T cells in vitro-its implication in the pathogenesis of adult T cell leukemia (ATL). Hum. Cell, 5: 70-78, 1992.
21. Nagahara, H., Vocero-Akbani, A. M., Snyder, E. L., Ho, A., Latham, D. G., Lissy, N. A., Becker-Hapak, M., Ezhevsky, S. A., and Dowdy, S. F. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat. Med., 4: 1449-1452, 1998.
22. Harada, H., Hiraoka, M., and Kizaka-Kondoh, S. Antitumor effect of TAT-oxygen-dependent degradation-caspase-3 fusion protein specifically stabilized and activated in hypoxic tumor cells. Cancer Res., 62: 2013-2018, 2002.
23. Makino, S., Masutani, H., Maekawa, N., Konishi, I., Fujii, S., Yamamoto, R., and Yodoi, J. Adult T-cell leukaemia-derived factor/thioredoxin expression on the HTLV-I transformed T-cell lines: heterogeneous expression in ALT-2 cells. Immunology, 76: 578-583, 1992.
24. Sherr, C. J. Cancer cell cycles. Science (Wash. DC), 274: 1672-1677, 1996.
25. Nosaka, K., Maeda, M., Tamiya, S., Sakai, T., Mitsuya, H., and Matsuoka, M. Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia. Cancer Res., 60: 1043-1048, 2000.
26. Rocco, J. W., and Sidransky, D. p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp. Cell Res., 264: 42-55, 2001.
27. Penna, G., and Adorini, L. 1α,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol., 164: 2405-2411, 2000.
28. Butler, L. M., Zhou, X., Xu, W. S., Scher, H. I., Rifkind, R. A., Marks, P. A., and Richon, V. M. The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. Proc. Natl. Acad. Sci. USA, 99: 11700-11705, 2002.
29. Takahashi, Y., Nagata, T., Ishii, Y., Ikarashi, M., Ishikawa, K., and Asai, S. Up-regulation of vitamin D3 up-regulated protein 1 gene in response to 5-fluorouracil in colon carcinoma SW620. Oncol. Rep., 9: 75-79, 2002.
30. Young, L. H., Yang, X., and Voigt, J. M. Alteration of gene expression in rat mammary tumors induced by N-methyl-N-nitrosourea. Mol. Carcinog., 15: 251-260, 1996.
31. Joguchi, A., Otsuka, I., Minagawa, S., Suzuki, T., Fujii, M., and Ayusawa, D. Overexpression of VDUP1 mRNA sensitizes HeLa cells to paraquat. Biochem. Biophys. Res. Commun., 293: 293-297, 2002.
32. Migone, T. S., Lin, J. X., Cereseto, A., Mulloy, J. C., O'Shea, J. J., Franchini, G., and Leonard, W. J. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science (Wash. DC), 269: 79-81, 1995.
33. Wakasugi, N., Tagaya, Y., Wakasugi, H., Mitsui, A., Maeda, M., Yodoi, J., and Tursz, T. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc. Natl. Acad. Sci. USA, 87: 8282-8286, 1990.
34. Tagaya, Y., Wakasugi, H., Masutani, H., Nakamura, H., Iwata, S., Mitsui, A., Fujii, S., Wakasugi, N., Tursz, T., and Yodoi, J. Role of ATL-derived factor (ADF) in the normal and abnormal cellular activation: involvement of dithiol related reduction. Mol. Immunol., 27: 1279-1289, 1990.
35. Iwata, S., Hori, T., Sato, N., Ueda-Taniguchi, Y., Yamabe, T., Nakamura, H., Masutani, H., and Yodoi, J. Thiol-mediated redox regulation of lymphocyte proliferation. Possible involvement of adult T cell leukemia-derived factor and glutathione in transferrin receptor expression. J. Immunol., 152: 5633-5642, 1994.
36. Sato, N., Iwata, S., Nakamura, K., Hori, T., Mori, K., and Yodoi, J. Thiol-mediated redox regulation of apoptosis. Possible roles of cellular thiols other than glutathione in T cell apoptosis. J. Immunol., 154: 3194-3203, 1995.
37. Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., and Ichijo, H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J., 17: 2596-2606, 1998.
38. Hirota, K., Matsui, M., Iwata, S., Nishiyama, A., Mori, K., and Yodoi, J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. USA, 94: 3633-3638, 1997.
39. Ueno, M., Masutani, H., Arai, R. J., Yamauchi, A., Hirota, K., Sakai, T., Inamoto, T., Yamaoka, Y., Yodoi, J., and Nikaido, T. Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J. Biol. Chem., 274: 35809-35815, 1999.
40. Gallegos, A., Gasdaska, J. R., Taylor, C. W., Paine-Murrieta, G. D., Goodman, D., Gasdaska, P. Y., Berggren, M., Briehl, M. M., and Powis, G. Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells. Cancer Res., 56: 5765-5770, 1996.